Assessment of quality of life in the treatment of major depressive disorder with fluoxetine, 20 mg, in ambulatory patients aged over 60 years.
Mesters
P
P
Eli Lilly Benelux SA, Brussels, Belgium.
Cosyns
P
P
Dejaiffe
G
G
Fanielle
J
J
Gilles
C
C
Godderis
J
J
Grégoire
J
J
de Leval
N
N
Meire
P
P
Mesotten
F
F
D000368:Aged; D000553:Ambulatory Care; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects / Q000627:therapeutic use*; D015577:Geriatric Assessment; D006801:Humans; D008297:Male; D008875:Middle Aged; D010555:Personality Inventory; D011788:Quality of Life
D005473:Fluoxetine